US 11642339
Methods of treating symptoms of gastroparesis using velusetrag
granted A61KA61K31/4704A61K31/55
Quick answer
US patent 11642339 (Methods of treating symptoms of gastroparesis using velusetrag) held by Theravance Biopharma R&D IP, LLC expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4704, A61K31/55, A61K9/4858, A61K9/4866